Literature DB >> 25790774

Utilizing the Multiradionuclide Resolving Power of SPECT and Dual Radiolabeled Single Molecules to Assess Treatment Response of Tumors.

Baogang Xu1, Monica Shokeen2, Gail P Sudlow2, Scott E Harpstrite2, Kexian Liang2, Philip P Cheney2, W Barry Edwards2, Vijay Sharma2, Richard Laforest2, Walter J Akers2, Samuel Achilefu3.   

Abstract

PURPOSE: Single photon emission computed tomography (SPECT) <span class="Chemical">radionuclide pairs having distinct decay rates and different energy maxima enable simultaneous detection of dual gamma signals and real-time assessment of dynamic functional and molecular processes in vivo. Here, we report image acquisition and quantification protocols for a single molecule labeled with two different radionuclides for functional SPECT imaging. PROCEDURES: LS370 and LS734 were prepared using modular solid phase peptide synthesis. Each agent has a caspase-3 cleavable reporting motif, flanked by a tyrosine residue and a chelator at the opposite end of molecule. Cell uptake and efflux were assessed in human MDA-MB-231 breast cancer cells. Biodistribution studies were conducted in tumor naive and orthotopic 4T1 metastatic breast cancer tumor mice. NanoSPECT dual-imaging validation and attenuation correction parameters were developed using phantom vials containing varying radionuclide concentrations. Proof-of-principle SPECT imaging was performed in MMTV-PyMT transgenic mice.
RESULTS: LS370 and LS734 were singly or dually radiolabeled with (125)I and (111)In or (99m)Tc. Cell assays demonstrated 11-fold higher percent uptake (P < 0.001) of [(125)I]LS734 (3.6 ± 0.5) compared to [(125)I]LS370 (0.3 ± 0.3) at 2 h. Following chemotherapy, cellular retention of [(125)I]LS734 was 3-fold higher (P < 0.05) than untreated cells. Pharmacokinetics at 1 h postinjection demonstrated longer blood retention (%ID/g) for [(125)I]LS734 (3.2 ± 0.9) compared to [(125)I]LS370 (1.6 ± 0.1). In mice bearing bilateral orthotopic 4T1 tumors, the uptake (%ID/g) was 2.4 ± 0.3 for [(125)I]LS734 and 1.2 ± 0.03 for [(125)I]LS370. The iodinated tyrosine peptide residue label was stable under in vitro conditions for up to 24 h; rapid systemic deiodination (high thyroid uptake) was observed in vivo. Phantom studies using standards demonstrated deconvolution of radionuclide signals based on different gamma ray energies. In MMTV-PyMT mice imaged with dual-labeled [(111)In]-[(125)I]LS734, the gamma signals were separable and quantifiable.
CONCLUSIONS: Image processing protocols were developed for quantitative signal separation resulting from a caspase-3 responsive dual-radiolabeled SPECT probe. Crosstalk unmixing was obtained for multiradionuclide NanoSPECT imaging. In vitro and in vivo data demonstrated structure-activity relationships for developing functional agents for ratiometric SPECT imaging.

Entities:  

Keywords:  Apoptosis; Cancer; Caspase; Cleavable peptide; Programmed cell death; Radionuclide; SPECT

Mesh:

Substances:

Year:  2015        PMID: 25790774      PMCID: PMC4853202          DOI: 10.1007/s11307-015-0842-8

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  21 in total

1.  In vivo molecular target assessment of matrix metalloproteinase inhibition.

Authors:  C Bremer; C H Tung; R Weissleder
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

Review 2.  Clinical molecular imaging with radiotracers: current status.

Authors:  Michael M Graham
Journal:  Med Princ Pract       Date:  2011-11-30       Impact factor: 1.927

Review 3.  Optical imaging: current applications and future directions.

Authors:  Gary D Luker; Kathryn E Luker
Journal:  J Nucl Med       Date:  2007-12-12       Impact factor: 10.057

Review 4.  True radiotracers: are we approaching theoretical specific activity with Tc-99m and I-123?

Authors:  William C Eckelman; Mauro Bonardi; Wynn A Volkert
Journal:  Nucl Med Biol       Date:  2008-07       Impact factor: 2.408

Review 5.  Anticancer therapy and apoptosis imaging.

Authors:  T J Yang; A Haimovitz-Friedman; M Verheij
Journal:  Exp Oncol       Date:  2012-10

6.  Radiolabeled isatin binding to caspase-3 activation induced by anti-Fas antibody.

Authors:  Delphine L Chen; Dong Zhou; Wenhua Chu; Phillip Herrbrich; Jacquelyn T Engle; Elizabeth Griffin; Lynne A Jones; Justin M Rothfuss; Marco Geraci; Richard S Hotchkiss; Robert H Mach
Journal:  Nucl Med Biol       Date:  2011-10-26       Impact factor: 2.408

7.  Residualizing iodine markedly improved tumor targeting using bispecific antibody-based pretargeting.

Authors:  Frank G van Schaijk; Matthias Broekema; Egbert Oosterwijk; Juliette E M van Eerd; Bill J McBride; David M Goldenberg; Frans H M Corstens; Otto C Boerman
Journal:  J Nucl Med       Date:  2005-06       Impact factor: 10.057

8.  Multimodal imaging of integrin receptor-positive tumors by bioluminescence, fluorescence, gamma scintigraphy, and single-photon emission computed tomography using a cyclic RGD peptide labeled with a near-infrared fluorescent dye and a radionuclide.

Authors:  W Barry Edwards; Walter J Akers; Yunpeng Ye; Philip P Cheney; Sharon Bloch; Baogang Xu; Richard Laforest; Samuel Achilefu
Journal:  Mol Imaging       Date:  2009 Mar-Apr       Impact factor: 4.488

9.  Protease-activated drug development.

Authors:  Ki Young Choi; Magdalena Swierczewska; Seulki Lee; Xiaoyuan Chen
Journal:  Theranostics       Date:  2012-02-08       Impact factor: 11.556

Review 10.  Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography.

Authors:  François Bénard; Eric Turcotte
Journal:  Breast Cancer Res       Date:  2005-05-12       Impact factor: 6.466

View more
  2 in total

Review 1.  Imaging-based diagnosis of acute renal allograft rejection.

Authors:  Gerold Thölking; Katharina Schuette-Nuetgen; Dominik Kentrup; Helga Pawelski; Stefan Reuter
Journal:  World J Transplant       Date:  2016-03-24

2.  Simultaneous SPECT imaging of multi-targets to assist in identifying hepatic lesions.

Authors:  Zhide Guo; Mengna Gao; Deliang Zhang; Yesen Li; Manli Song; Rongqiang Zhuang; Xinhui Su; Guibing Chen; Ting Liu; Pingguo Liu; Hua Wu; Jin Du; Xianzhong Zhang
Journal:  Sci Rep       Date:  2016-07-05       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.